Abstract
Aim:
To investigate the effects of insulin on enhancing 5-fluorouracil (5-FU) anti-cancer functions and its mechanisms in the human esophageal cancer cell line (Eca 109) and human colonic cancer cell line (Ls-174-t).
Methods:
The effect of insulin/5-FU combination treatment on the growth of Eca 109 and Ls-174-t cells was evaluated by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) assay. After insulin treatment or insulin/5-FU treatment, cell cycle distribution of both cell lines was analyzed by flow cytometry. Western blot assay was used to assess the expression of caspase-3 and thymidylate synthase (TS). Apoptosis was detected by flow cytometry, DNA fragmentation assay, and terminal transferase dUTP nick end labeling assay (TUNEL). Moreover, the changes of 5-FU uptake after insulin pretreatment were detected by HPLC assay and Western blot analysis.
Results:
We found that insulin enhanced the inhibitory effect of 5-FU on cell proliferation when Eca 109 cells and Ls-174-t cells were pretreated with insulin for the appropriate time. Insulin increased the cell number of the S phase and the uptake of 5-FU. Insulin/5-FU treatment enhanced apoptosis of tumor cells and upregulated the expression of cleaved caspase-3 compared with 5-FU treatment. Moreover, insulin/5-FU treatment induced the changes of free TS and the TS ternary complex level compared with 5-FU treatment in Eca 109 and Ls-174-t cells.
Conclusion:
These data suggest that insulin enhances anticancer functions of 5-FU when it is treated before 5-FU for the appropriate time in human esophageal and colonic cancer cell lines.
Similar content being viewed by others
Article PDF
References
Paradiso A, Xu J, Mangia A, Chiriatti A, Simone G, Zito A, et al. Topoisomerase-I, thymidylate synthase primary tumour expression and clinical efficacy of 5–FU/CPT-11 chemotherapy in advanced colorectal cancer patients. Int J Cancer 2004; 111: 252–8.
Fryar EB, Das JR, Davis JH, Desoto JA, Laniyan I, Southerland WM, et al. Raloxifene attenuation of 5–FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy. Anticancer Res 2006; 26: 1861–7.
Prevost A, Merol JC, Aime P, Moutel K, Roger-Liautaud F, Nasca S, et al. A randomized trial between two neoadjuvant chemotherapy protocols: CDDP+5-FU versus CDDP+VP16 in advanced cancer of the head and neck. Oncol Rep 2005; 14: 771–6.
Fukushima M, Fujioka A, Uchida J, Nakagawa F, Takechi T . Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. Eur J Cancer 2001; 37: 1681–7.
van Kuilenburg AB . Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer 2004; 40: 939–50.
Longley DB, Harkin DP, Johnston PG . 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3: 330–8.
Loeffler M, Kruger JA, Niethammer AG, Reisfeld RA . Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J Clin Invest 2006; 116: 1955–62.
Gottesman MM . Mechanisms of cancer drug resistance. Annu Rev Med 2002; 53: 615–27.
Shah MA, Schwartz GK . Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 2001; 7: 2168–81.
Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW . Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 2004; 23: 2934–49.
Makin G, Dive C . Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy? Breast Cancer Res 2001; 3: 150–3.
De Meyts P . Insulin and its receptor: structure, function and evolution. Bioessays 2004; 26: 1351–62.
Furtado LM, Somwar R, Sweeney G, Niu W, Klip A . Activation of the glucose transporter GLUT4 by insulin. Biochem Cell Biol 2002; 80: 569–78.
Acevedo CG, Marquez JL, Rojas S, Bravo I . Insulin and nitric oxide stimulates glucose transport in human placenta. Life Sci 2005; 76: 2643–53.
Gu S, Villegas CJ, Jiang JX . Differential regulation of amino acid transporter SNAT3 by insulin in hepatocytes. J Biol Chem 2005; 280: 26055–62.
Al-Khalili L, Kotova O, Tsuchida H, Ehren I, Feraille E, Krook A, et al. ERK1/2 mediates insulin stimulation of Na(+), K(+)-ATPase by phosphorylation of the alpha-subunit in human skeletal muscle cells. J Biol Chem 2004; 279: 25211–8.
Rosic NK, Standaert ML, Pollet RJ . The mechanism of insulin stimulation of (Na+, K+)-ATPase transport activity in muscle. J Biol Chem 1985; 260: 6206–12.
Xu JM, Song ST, Tang ZM, Liu XQ, Jiang ZF, Zhou L, et al. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer. Breast Cancer Res Treat 1998; 49: 251–9.
Lautamaki R, Airaksinen KE, Seppanen M, Toikka J, Harkonen R, Luotolahti M, et al. Insulin improves myocardial blood flow in patients with type 2 diabetes and coronary artery disease. Diabetes 2006; 55: 511–6.
Sauer WH, Cappola AR, Berlin JA, Kimmel SE . Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus. Am J Cardiol 2006; 97: 651–4.
Lasalvia-Prisco E, Cucchi S, Vazquez J, Lasalvia-Galante E, Golomar W, Gordon W . Insulin-induced enhancement of antitumoral response to methotrexate in breast cancer patients. Cancer Chemother Pharmacol 2004; 53: 220–4.
Jiao SC, Huang J, Sun Y, Lu SX . The effect of insulin on chemo-therapeutic drug sensitivity in human esophageal and lung cancer cells. Zhonghua Yi Xue Za Zhi 2003; 83: 195–7. Chinese.
O'Connor PM, Kohn KW . A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Semin Cancer Biol 1992; 3: 409–16.
Boumah CE, Setterfield G, Kaplan JG . Purine and pyrimidine analogues irreversibly prevent passage of lymphocytes from the G1 to the S phase of the cell cycle. Can J Biochem Cell Biol 1984; 62: 280–7.
Jedema I, Barge RM, Nijmeijer BA, Willemze R, Falkenburg JH . Recruitment of leukemic cells from G0 phase of the cell cycle by interferons results in conversion of resistance to daunorubicin. Leukemia 2003; 17: 2049–51.
Yuasa H, Matsuhisa E, Watanabe J . Intestinal brush border transport mechanism of 5-fluorouracil in rats. Biol Pharm Bull 1996; 19: 94–9.
Hickman JA . Apoptosis and chemotherapy resistance. Eur J Cancer 1996; 32A: 921–6.
Amantana A, London CA, Iversen PL, Devi GR . X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 2004; 3: 699–707.
Adachi Y, Taketani S, Oyaizu H, Ikebukuro K, Tokunaga R, Ikehara S . Apoptosis of colorectal adenocarcinoma induced by 5–FU and/or IFN-gamma through caspase 3 and caspase 8. Int J Oncol 1999; 15: 1191–6.
Yang Z, Cloud A, Hughes D, Johnson LF . Stable inhibition of human thymidylate synthase expression following retroviral introduction of an siRNA gene. Cancer Gene Ther 2006; 13: 107–14.
Curtin NJ, Harris AL, Aherne GW . Mechanism of cell death following thymidylate synthase inhibition: 2′-deoxyuridine-5′-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole. Cancer Res 1991; 51: 2346–52.
Mandel HG . The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role? Cancer Treat Rep 1981; 65 Suppl 3: 63–71.
Ota D, Kusama M, Kaise H, Nakayama S, Misaka T, Tsuchida A, et al. Evaluation of sensitivity to 5–FU on the basis of thymidylate synthase (TS)/dihydropyrimidine dehydrogenase (DPD) activity and chromosomal analysis in micro tissue specimens of breast cancer. Breast Cancer 2004; 11: 356–66.
van Triest B, Peters GJ . Thymidylate synthase: a target for combination therapy and determinant of chemotherapeutic response in colorectal cancer. Oncology 1999; 57: 179–94.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zou, K., Ju, Jh. & Xie, H. Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells. Acta Pharmacol Sin 28, 721–730 (2007). https://doi.org/10.1111/j.1745-7254.2007.00554.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00554.x
Keywords
This article is cited by
-
Co-delivery of chemotherapeutic drugs and cell cycle regulatory agents using nanocarriers for cancer therapy
Science China Materials (2021)
-
Insulin enhancement of the antitumor activity of chemotherapeutic agents in colorectal cancer is linked with downregulating PIK3CA and GRB2
Scientific Reports (2019)
-
The effect of IGF-I receptor blockade for human esophageal squamous cell carcinoma and adenocarcinoma
Tumor Biology (2014)
-
Anticancer effects of 5-fluorouracil combined with warming and relieving cold phlegm formula on human breast cancer
Chinese Journal of Integrative Medicine (2012)